Filing Details
- Accession Number:
- 0001654954-25-003907
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-04-04 08:23:32
- Reporting Period:
- 2025-01-22
- Filing Date:
- 2025-04-04
- Accepted Time:
- 2025-04-04 08:23:32
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1101026 | Zivo Bioscience Inc. | ZIVO | Biological Products, (No Disgnostic Substances) (2836) | 870699977 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1641073 | L Laith Yaldoo | Bloomfield Hills MI 48302 | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2025-01-22 | 7,200 | $17.53 | 551,746 | No | 4 | P | Indirect | By HEP Investments LLC |
Common Stock | Acquisiton | 2025-01-22 | 2,880 | $17.53 | 554,626 | No | 4 | P | Indirect | By HEP Investments LLC |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | By HEP Investments LLC |
No | 4 | P | Indirect | By HEP Investments LLC |
Footnotes
- The shares were acquired in exchange for the release of certain obligations of the Company under the License Co-Development Participation Agreement.
- The shares were acquired in exchange for the release of certain obligations of the Company under the License Co-Development Participation Agreement.